Albuminuria and chronic kidney disease in association with the metabolic syndrome.

Toshiharu Ninomiya, Yutaka Kiyohara

研究成果: ジャーナルへの寄稿評論記事

26 引用 (Scopus)

抄録

Chronic kidney disease is a worldwide public health problem because it is an important risk factor for cardiovascular disease and premature death. The metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, impaired glucose tolerance, and dyslipidemia, is also an increasingly common disorder and a major risk factor for diabetes and cardiovascular disease. A close association has been found between the metabolic syndrome and the risk for developing renal impairment, clinically expressed in the form of microalbuminuria or chronic kidney disease. Several potential mechanisms, including insulin resistance, renal atherosclerosis, and inflammation, induce the deterioration of renal function. Despite the close association between the metabolic syndrome and renal impairment, it is still unclear whether and to what extent treating the metabolic syndrome will prevent renal impairment. A clinical trial is needed to clarify whether the effect of preventing and treating metabolic syndrome components will result in improved renal prognosis.

元の言語英語
ページ(範囲)104-107
ページ数4
ジャーナルJournal of the cardiometabolic syndrome
2
発行部数2
DOI
出版物ステータス出版済み - 1 1 2007

Fingerprint

Albuminuria
Chronic Renal Insufficiency
Kidney
Cardiovascular Diseases
Premature Mortality
Glucose Intolerance
Abdominal Obesity
Dyslipidemias
Insulin Resistance
Atherosclerosis
Public Health
Clinical Trials
Hypertension
Inflammation

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

これを引用

Albuminuria and chronic kidney disease in association with the metabolic syndrome. / Ninomiya, Toshiharu; Kiyohara, Yutaka.

:: Journal of the cardiometabolic syndrome, 巻 2, 番号 2, 01.01.2007, p. 104-107.

研究成果: ジャーナルへの寄稿評論記事

@article{3fa4a71a20db4ad68135cfc65b2e09b0,
title = "Albuminuria and chronic kidney disease in association with the metabolic syndrome.",
abstract = "Chronic kidney disease is a worldwide public health problem because it is an important risk factor for cardiovascular disease and premature death. The metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, impaired glucose tolerance, and dyslipidemia, is also an increasingly common disorder and a major risk factor for diabetes and cardiovascular disease. A close association has been found between the metabolic syndrome and the risk for developing renal impairment, clinically expressed in the form of microalbuminuria or chronic kidney disease. Several potential mechanisms, including insulin resistance, renal atherosclerosis, and inflammation, induce the deterioration of renal function. Despite the close association between the metabolic syndrome and renal impairment, it is still unclear whether and to what extent treating the metabolic syndrome will prevent renal impairment. A clinical trial is needed to clarify whether the effect of preventing and treating metabolic syndrome components will result in improved renal prognosis.",
author = "Toshiharu Ninomiya and Yutaka Kiyohara",
year = "2007",
month = "1",
day = "1",
doi = "10.1111/j.1559-4564.2007.05734.x",
language = "English",
volume = "2",
pages = "104--107",
journal = "Journal of Clinical Hypertension",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Albuminuria and chronic kidney disease in association with the metabolic syndrome.

AU - Ninomiya, Toshiharu

AU - Kiyohara, Yutaka

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Chronic kidney disease is a worldwide public health problem because it is an important risk factor for cardiovascular disease and premature death. The metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, impaired glucose tolerance, and dyslipidemia, is also an increasingly common disorder and a major risk factor for diabetes and cardiovascular disease. A close association has been found between the metabolic syndrome and the risk for developing renal impairment, clinically expressed in the form of microalbuminuria or chronic kidney disease. Several potential mechanisms, including insulin resistance, renal atherosclerosis, and inflammation, induce the deterioration of renal function. Despite the close association between the metabolic syndrome and renal impairment, it is still unclear whether and to what extent treating the metabolic syndrome will prevent renal impairment. A clinical trial is needed to clarify whether the effect of preventing and treating metabolic syndrome components will result in improved renal prognosis.

AB - Chronic kidney disease is a worldwide public health problem because it is an important risk factor for cardiovascular disease and premature death. The metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, impaired glucose tolerance, and dyslipidemia, is also an increasingly common disorder and a major risk factor for diabetes and cardiovascular disease. A close association has been found between the metabolic syndrome and the risk for developing renal impairment, clinically expressed in the form of microalbuminuria or chronic kidney disease. Several potential mechanisms, including insulin resistance, renal atherosclerosis, and inflammation, induce the deterioration of renal function. Despite the close association between the metabolic syndrome and renal impairment, it is still unclear whether and to what extent treating the metabolic syndrome will prevent renal impairment. A clinical trial is needed to clarify whether the effect of preventing and treating metabolic syndrome components will result in improved renal prognosis.

UR - http://www.scopus.com/inward/record.url?scp=34548443699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548443699&partnerID=8YFLogxK

U2 - 10.1111/j.1559-4564.2007.05734.x

DO - 10.1111/j.1559-4564.2007.05734.x

M3 - Review article

C2 - 17684460

AN - SCOPUS:34548443699

VL - 2

SP - 104

EP - 107

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

SN - 1524-6175

IS - 2

ER -